Answers are grounded in this paper and cite their sources.
Primary sclerosing cholangitis (PSC) is a chronic inflammatory cholestatic liver disease of unknown aetiology, characterized by the progressive development of strictures involving the intrahepatic and extrahepatic biliary tree, ultimately leading to end-stage liver disease and an increased risk of cholangiocarcinoma. Approximately half of patients with PSC develop multiple biliary strictures over the course of the disease, which may result in infectious complications and obstructive jaundice. Importantly, these strictures may harbour dysplasia or malignancy; however, distinguishing benign inflammatory or fibrotic strictures from malignant lesions remains particularly challenging based on radiological findings alone. Endoscopy, particularly endoscopic retrograde cholangiopancreatography (ERCP), plays a pivotal role in both the diagnostic evaluation and therapeutic management of patients with PSC. In recent years, substantial advances have been made in endoscopic techniques aimed at improving diagnostic accuracy, with peroral cholangioscopy emerging as a particularly promising modality. In this review, we summarize the current role of endoscopic therapy and discuss recent and emerging advances in endoscopic diagnostic strategies for patients with PSC.
No takes yet. Share an insight, caveat, or question.
Giorgio et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: